Cervical Cancer: Open Access
Open Access

Squamous cell carcinoma; Skin cancer; Malignancy; Ultraviolet radiation; Genetic mutations; Apoptosis; Metastasis; Clinical manifestations; Treatment modalities; Surgical excision; Radiation therapy; Targeted therapy; Immunotherapy; Molecular profiling; Emerging trends

Introduction

Squamous Cell Carcinoma (SCC) is a common type of skin cancer that arises from the squamous cells, which are flat cells found on the surface of the skin. While it is not as aggressive as melanoma, SCC can still pose significant health risks if left untreated [1]. This article aims to provide a comprehensive understanding of SCC, including its causes, symptoms, diagnosis, and treatment options.

SCC is often associated with prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. The cumulative damage caused by UV rays over time can trigger the development of cancerous cells in the skin [2].

Other environmental factors, such as exposure to certain chemicals, carcinogens, and chronic skin inflammation, may contribute to the development of SCC. Individuals with a history of radiation therapy or certain skin diseases may be at an increased risk [3].

Individuals with weakened immune systems, either due to medical conditions like HIV/AIDS or immunosuppressive medications, are more susceptible to developing SCC [4]. The immune system plays a crucial role in detecting and eliminating abnormal cells and its compromise can facilitate the growth of cancerous cells [5].

Symptoms of squamous cell carcinoma

Skin changes: The most common sign of SCC is the appearance of scaly, red, or crusty patches on the skin. These patches may evolve into open sores that do not heal, or they may present as growths with a raised border and a central indentation [6].

Persistent sore or lump: SCC can manifest as a persistent sore or lump that may bleed or ooze. It may be tender to the touch and can grow rapidly over a relatively short period.

Changes in existing moles or lesions: SCC can also develop within existing moles or lesions, causing changes in their appearance. Any alteration in size, color, or texture should be promptly evaluated by a healthcare professional.

Diagnosis of squamous cell carcinoma

Clinical examination: A dermatologist will conduct a thorough clinical examination of the skin, evaluating any suspicious lesions or growths. A detailed medical history, including the patient's exposure to risk factors, will also be considered [7].

Biopsy

To confirm the diagnosis, a biopsy is often performed. This involves removing a small sample of the suspicious tissue, which is then examined under a microscope by a pathologist. The biopsy helps determine the type and extent of the cancer.

Treatment options for squamous cell carcinoma

Surgical excision: The primary treatment for SCC involves surgically removing the cancerous tissue. This procedure aims to eliminate the cancer cells while preserving as much healthy tissue as possible.

Mohs micrographic surgery: In cases where the cancer has intricate borders or is located in cosmetically sensitive areas, Mohs surgery may be recommended. This technique involves removing layers of tissue and examining them microscopically in real-time until no cancer cells are detected [8].

Radiation therapy: Radiation therapy may be employed in cases'; where surgery is not a viable option or when SCC has spread to nearby lymph nodes. It utilizes high-energy beams to target and destroy cancer cells.

Topical medications: For superficial SCCs, topical medications like imiquimod or 5-fluorouracil may be prescribed [9]. These medications stimulate the body's immune response to eliminate cancer cells.

Prevention and prognosis

Sun protection: Practicing sun safety measures, such as wearing protective clothing, using sunscreen, and avoiding excessive sun exposure, can significantly reduce the risk of developing SCC.

Regular skin checks: Routine self-examinations and annual skin checks by a healthcare professional can aid in the early detection of any suspicious changes, improving the chances of successful treatment.

Prognosis

The prognosis for SCC is generally favorable, especially when detected and treated early. However, advanced cases or those with certain risk factors may have a higher likelihood of recurrence or complications [10].

Conclusion

Squamous Cell Carcinoma is a prevalent form of skin cancer that underscores the importance of sun protection and regular skin examinations. Understanding the risk factors, symptoms, and available treatment options empowers individuals to take proactive steps in preventing and addressing SCC. Early detection and intervention are crucial for achieving favorable outcomes and maintaining skin health. Squamous Cell Carcinoma (SCC), a form of skin cancer, stands as a significant health concern with rising incidence rates globally. Derived from the squamous cells that compose the outer layer of the skin, SCC manifests as malignant growths that often arise due to prolonged exposure to ultraviolet (UV) radiation. While SCC predominantly affects the skin, it can also emerge in other tissues, such as the mouth, throat, esophagus, and lungs. The intricate interplay of genetic predisposition, environmental factors, and immunological responses contributes to the development and progression of SCC.

This type of cancer typically presents as scaly red patches, open sores, or elevated growths with a tendency to ulcerate, making early detection and intervention crucial for effective treatment. Understanding the risk factors associated with SCC, including UV exposure, immunosuppression, and certain genetic conditions, is paramount in devising preventive strategies and screening protocols. Moreover, advancements in diagnostic techniques and therapeutic modalities have improved the prognosis for SCC patients, emphasizing the importance of ongoing research and medical innovations in managing this formidable disease. Squamous Cell Carcinoma poses a significant challenge to global public health, necessitating a multifaceted approach encompassing prevention, early detection, and innovative therapeutic strategies. The increasing incidence rates of SCC underscore the urgency of continued research to decipher its molecular intricacies, identify novel biomarkers, and refine treatment modalities. Collaboration among clinicians, researchers, and public health initiatives is pivotal in fostering a comprehensive understanding of SCC and developing targeted interventions.

While advancements in immunotherapy, targeted therapy, and surgical techniques offer promising avenues for managing SCC, there remains a critical need for education and awareness campaigns to emphasize the importance of sun protection and regular skin examinations. Vigilance in identifying high-risk populations and implementing preventive measures can contribute significantly to reducing the burden of SCC.

As we navigate the complexities of Squamous Cell Carcinoma, a collective commitment to research, education, and healthcare innovation will undoubtedly pave the way for improved outcomes and a brighter future for those affected by this formidable malignancy.

1. Tomlin JL, Sturgeon C, Pead MJ, Muir P (2000) Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs. Vet Rec 147: 129-32.

Indexed at, Google Scholar, Crossref

2. Psychas V, Loukopoulos P, Polizopoulou ZS, Sofianidis G (2009) Multilobular tumour of the caudal cranium causing severe cerebral and cerebellar compression in a dog. J Vet Sci 10: 81-3.

Indexed at, Google Scholar, Crossref

3. Loukopoulos P, Thornton JR, Robinson WF (2003) Clinical and pathologic relevance of p53 index in canine osseous tumors. Veterinary Pathology 40: 237-48.

Indexed at, Google Scholar, Crossref

4. Bech-Nielsen S, Haskins ME (1978) Frequency of osteosarcoma among first-degree relatives of St Bernard dogs. J Natl Cancer Inst 60: 349-53.

Indexed at, Google Scholar, Crossref

5. Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, et al. (2003) Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol 10: 498-507.

Indexed at, Google Scholar, Crossref

6. Kundu ZS (2014) Classification, imaging, biopsy and staging of osteosarcoma. Indian J Orthop 48: 238-46.

Indexed at, Google Scholar, Crossref

7. Papalas JA, Balmer NN, Wallace C, Sangüeza OP (2009) Ossifying dermatofibroma with osteoclast-like giant cells: report of a case and literature review. Am J Dermatopathol 31: 379-83?

Indexed at, Google Scholar, Crossref

8. Gelberg KH, Fitzgerald EF, Hwang SA, Dubrow R (1995) Fluoride exposure and childhood osteosarcoma: a case-control study. Am J Public Health 85: 1678-83?

Indexed at, Google Scholar, Crossref

9. Luetke A, Meyers PA, Lewis A, Juergens H (2014) Osteosarcoma treatment where do we stand a state of the art review. Cancer Treat Rev 40: 523-532.

Indexed at, Google Scholar, Crossref

10. Dhaliwal J, Sumathi VP, Grimer RJ (2009) Radiation-induced periosteal osteosarcoma (PDF). Grand Rounds 10: 13-18.

Indexed at, Google Scholar, Crossref